The Life Sciences industry is under the increasing pressure of competing on cost while still delivering the most effective medicines and medical devices to the market under the constantly tightening regulated conditions. Pressure from Asia, from generics, and from the saturated market have forced most companies to look at their internal cost structure in manufacturing, quality, sales, marketing, R&D and in their overall networks. At Tefen, we have worked with the world's leading life sciences companies to help transform their operations to become faster, more stable and more cost effective, and the results speak for themselves. Projects result in a 30% reduction in operating costs over three years, a 50% reduction in overall lead time and a significant sales improvement.